Series E - Alector - 2018-07-25 - Crunchbase Funding Round Profile

Jul 25, 2018 · Alector raised $133000000 on 2018-07-25 in Series E. Google Ventures Google Ventures is an investment arm of Alphabet that provides seed, venture, and growth-stage …

CouponFollow Extension

$133000000
OFF

Series E - Alector - 2018-07-25 - Crunchbase Funding Round Profile

1 week from now

Jul 25, 2018 · Alector raised $133000000 on 2018-07-25 in Series E. Google Ventures Google Ventures is an investment arm of Alphabet that provides seed, venture, and growth-stage …

crunchbase.com

$133
OFF

AbbVie-Backed Startup Raises $133 Million To Fight Alzheimer's

1 week from now

This Series E funding round brings Alector's total fundraising amount since the company was founded in 2013 to more than $400 million, counting both venture capital investments and a …

forbes.com

$133
OFF

Alector - Company Profile - Tracxn

1 week from now

Oct 19, 2024 · What are the most recent funding rounds of Alector? Its latest funding round was a Series E round on Jul 25, 2018 for $133M. 16 investors participated in its latest round, which …

tracxn.com

$215
OFF

Alector - Raised $215M Funding From 19 Investors - Tracxn

1 week from now

Nov 5, 2024 · List of Alector's institutional investors. Deerfield, located in New York City (United States), made their first investment in Alector on Jul 25, 2018 in its Series E round.; AbbVie, …

tracxn.com

$133
OFF

Alector Raises $133 Million In Series E Round For Neurology Drug ...

1 week from now

By Alaric DeArment on July 25, 2018. ... California-based Alector said Wednesday that it had raised $133 million in a Series E funding round. The round brought in a large group of …

medcitynews.com

$133
OFF

Biotech Company Alector Raises $133M In Series E Financing

1 week from now

Jul 27, 2018 · Alector, a South Francisco, CA-based biotechnology company focused on developing therapies that harness the immune system to cure neurodegenerative diseases …

finsmes.com

$133
OFF

Alector Funding Round

1 week from now

Jul 26, 2018 · The round was announced on 7/26/2018. AbbVie Biotech Ventures, Amgen Ventures and Casdin Capital invested in a $133 million Series E venture round for Alector. …

gaebler.com

$133
OFF

Alector Announces $133 Million In Series E Financing To ... - BioSpace

1 week from now

Jul 25, 2018 · SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Alector, a privately held biotechnology company focused on developing therapies that harness the immune system to cure neurodegenerative diseases and cancer, today announced the closing of a $133 million Series E financing.The proceeds from the financing will be used to advance Alector’s clinical programs …

biospace.com

$133
OFF

Alzheimer's-focused Alector Raises $133 Million - San Francisco ...

1 week from now

Jul 25, 2018 Growing Alector LLC raised $133 million — one of the largest, if not the biggest, venture rounds in biotech this year — that signals its intent to go public as it follows a ...

bizjournals.com

$133
OFF

Alector Raises $133M In 5th VC Round To Push Neuro-immunology …

1 week from now

Jul 25, 2018 · To fund Alector’s clinical trials, the series E financing round was backed by a syndicate of at least 17 high-profile investors, including the VC arms of AbbVie, Amgen and …

fiercebiotech.com

$133
OFF

Alector Announces $133M Series E - PitchBook

1 week from now

Jul 26, 2018 · Alector, which develops therapies for neurodegenerative diseases and cancer, has raised the funds from investors including GV, Section 32 and Euclidean Capital. ... Alector …

pitchbook.com

$19.00
OFF

Alector - Funding, Financials, Valuation & Investors - Crunchbase

1 week from now

Their latest funding was raised on Jan 17, 2024 from a Post-IPO Equity round. Alector is registered under the ticker NASDAQ:ALEC . Their stock opened with $19.00 in its Feb 7, 2019 …

crunchbase.com

$32
OFF

Our History Overview - Alector

1 week from now

Dementia Discovery Fund, an innovative global investment fund launched in October 2015, chooses Alector for first award. Raised $32M in Series C fund with investment from MRL …

alector.com

$194
OFF

Alector Stock Price, Funding, Valuation, Revenue & Financial …

1 week from now

Feb 7, 2019 · Funding, Valuation & Revenue. Alector has raised $194.5M over 7 rounds. Alector's latest funding round was a IPO for $166.5M on February 7, 2019. Alector's latest post-money …

cbinsights.com

$263000000
OFF

Series E - Snowflake - 2018-01-25 - Crunchbase Funding Round …

1 week from now

Jan 25, 2018 · Snowflake raised $263000000 on 2018-01-25 in Series E. Sequoia Capital Sequoia Capital is a VC firm that invests in startups in the energy, financial, enterprise, …

crunchbase.com

$30
OFF

Series E - Snapsheet - 2021-03-25 - Crunchbase Funding Round …

1 week from now

Mar 15, 2021 · Organization Name. Snapsheet. Announced Date Mar 25, 2021. Closed On Date Mar 15, 2021. Funding Type Series E. Funding Stage Late Stage Venture. Money Raised. $30M.

crunchbase.com

$200
OFF

Series E - Figma - 2021-06-24 - Crunchbase Funding Round Profile

1 week from now

Jun 24, 2021 · Organization Name. Figma. Announced Date Jun 24, 2021. Closed On Date Dec 2022. Funding Type Series E. Funding Stage Late Stage Venture. Money Raised. $200M. Pre …

crunchbase.com

$250
OFF

Series E - Reddit - 2021-02-08 - Crunchbase Funding Round Profile

1 week from now

Feb 8, 2021 · indulgexpress.com — Reddit raises $250M in the new Series E funding round. News • Feb 9, 2021. Crunchbase News — The Briefing: Branded Lands $150M, Reddit …

crunchbase.com

FAQs about Series E - Alector - 2018-07-25 - Crunchbase Funding Round Profile Coupon?

Where is Alector located?

Alector is located in San Francisco, California, United States. Who invested in Alector? Alector has 20 investors including OrbiMed and Mission Bay Capital. How much funding has Alector raised to date? Alector has raised When was the last funding round for Alector? Alector closed its last funding round on Jan 17, 2024 from a Post-IPO Equity round. ...

Who owns Alector?

Co-founders Arnon Rosenthal, Ph.D., Tillman Gerngross, Asa Abeliovich, Ph.D., and Errik Anderson launch Alector with announcement of Series A financing from Orbimed and Polaris Ventures Alector moves to life science incubator QB3 Alector is incorporated Selected Alector as the company name to represent heroic ideals ubiquitous in Greek mythology ...

What does Alector do?

Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel therapeutics for Alzheimer’s disease, other forms of dementia, and mechanistically related neurodegenerative disorders. Alector’s strategy is to efficiently generate and validate antibody drugs with unique ...

What is Alector's strategy?

Alector’s strategy is to efficiently generate and validate antibody drugs with unique functional properties that engage key disease-altering targets. This approach is enabled by a strategic alliance with Adimab, the industry leader in discovery and optimization of antibody therapeutics. ...

Who are Alector & Adimab?

Alector and Adimab announce strategic alliance to access antibody technologies Co-founders Arnon Rosenthal, Ph.D., Tillman Gerngross, Asa Abeliovich, Ph.D., and Errik Anderson launch Alector with announcement of Series A financing from Orbimed and Polaris Ventures ...

How long will Alector take to develop a lead?

Alector is currently developing leads for 4 major targets and anticipates taking 2 of these through pre-clinical development and IND enabling studies within 24 months. Alector has incorporated a highly integrated and lean biotechnology structure with extensive outsourcing that supports core scientific and management teams. ...